MedTrace Logo

Mouth Care Regimes During Radiotherapy

NCT00138827 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2005-12-15

No results posted yet for this study

Summary

The purpose of this study is to assess whether Biotene oral care products have a benefit in the treatment of xerostomia and mucositis when compared with conventional bicarbonate mouth care regimes.

Conditions

  • Head and Neck Neoplasms

Interventions

DRUG

Biotene (mouth care)

Sponsors & Collaborators

  • St George Hospital, Australia

    lead OTHER

Principal Investigators

  • Associate Professor Peter H Graham · St George Hospital, Sydney, Australia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-11-30
Completion
2003-03-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00138827 on ClinicalTrials.gov